MENU
+Compare
DYN
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$11.11
Change
+$0.33 (+3.06%)
Capitalization
1.13B

DYN Dyne Therapeutics Forecast, Technical & Fundamental Analysis

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases... Show more

DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for DYN with price predictions
Apr 23, 2025

DYN in +15.54% Uptrend, advancing for three consecutive days on April 23, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where DYN advanced for three days, in of 250 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where DYN's RSI Indicator exited the oversold zone, of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 21, 2025. You may want to consider a long position or call options on DYN as a result. In of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DYN just turned positive on April 17, 2025. Looking at past instances where DYN's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DYN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DYN broke above its upper Bollinger Band on April 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for DYN entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.788) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.992).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. DYN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DYN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

DYN is expected to report earnings to fall 2.98% to -85 cents per share on May 01

Dyne Therapeutics DYN Stock Earnings Reports
Q1'25
Est.
$-0.85
Q4'24
Beat
by $0.06
Q3'24
Missed
by $0.25
Q2'24
Beat
by $0.02
Q1'24
Missed
by $0.02
The last earnings report on February 27 showed earnings per share of -87 cents, beating the estimate of -93 cents. With 919.14K shares outstanding, the current market capitalization sits at 1.13B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Electric Utilities
Address
1560 Trapelo Road
Phone
+1 781 786-8230
Employees
141
Web
https://www.dyne-tx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSIAX39.26N/A
N/A
PGIM Quant Solutions Large-Cap Index A
FIFRX120.31N/A
N/A
Franklin Growth R6
MGLKX15.65N/A
N/A
MFS Global Real Estate R2
MLNCX20.80N/A
N/A
Morgan Stanley Instl Glbl Concntr C
WSACX24.79N/A
N/A
Wellington Shields All-Cap Instl

DYN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with CRNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+8.78%
CRNX - DYN
50%
Loosely correlated
+3.55%
ROIV - DYN
48%
Loosely correlated
+2.98%
INZY - DYN
47%
Loosely correlated
-4.84%
RNA - DYN
47%
Loosely correlated
+4.18%
ERAS - DYN
47%
Loosely correlated
+2.90%
More